Geneesmiddelenbeleid
This procedure concerns a written consultation report regarding the Dutch government's approach to medicines policy. It focuses on how pharmaceuticals are managed, regulated, and accessed to ensure public health and sustainability within the healthcare system. This affects healthcare providers, pharmaceutical companies, and patients by influencing the availability and pricing of essential medicines.
National vote coverage: Netherlands-only